Validación Científica y Certificaciones

Respaldado por Ciencia y Clínica

CandelStim no es un dispositivo experimental. Está validado por ensayos clínicos rigurosos en centros de referencia y cuenta con certificaciones internacionales.

Ensayos Clínicos Completados

1. Non-Inferiority Trial vs. Soterix Medical (Febrero 2023)

Objetivo: Demostrar equivalencia de CandelStim con estándar internacional de tDCS
Resultado: ✅ POSITIVO - Equivalencia confirmada en excitabilidad cerebral
Publicación: Datos disponibles en solicitud directa

2. Ensayo ACV Agudo y Crónico - Hospital Clínico U. Chile

Población: 80+ pacientes con ACV
Resultado: Mejoras significativas en recuperación motora (p<0.05)
Estado: Datos preliminares; publicación en preparación

3. Ensayo TEC + Telerehabilitación - Mutual de Seguridad

Población: 50+ pacientes con Traumatismo Encéfalo Craneano
Resultado: Aceleración de recuperación neurológica en 3-6 meses
Aplicación: Incorporado a protocolo estándar de rehabilitación laboral

Certificaciones Internacionales

  • ISO 13485: Sistema de gestión de calidad para dispositivos médicos ✅
  • IEC 60601-1: Seguridad de equipos médicos eléctricos (en proceso) ⏳
  • CERTEMED Chile: Trámite de certificación en curso ⏳

Seguridad Clínica Documentada

  • +200 pacientes en tratamiento activo sin eventos adversos serios reportados
  • Perfil de seguridad: Cefaleas leves transitorias (<5%), eritema local (<2%)
  • Contraindicaciones identificadas: Implantes metálicos intracerebrales, epilepsia no controlada, embarazo

Equipo de Asesores Científicos

Prof. Dr. Nigel Pedersen - Associate Professor Neurology, UC Davis | Epileptologist & Neuromodulation Specialist
Prof. Dr. Rómulo Fuentes - Director de Investigación, Facultad de Medicina U. Chile
Prof. Dr. José Manuel Matamala - Neurólogo, Clínica Alemana | PhD Ciencias Médicas

Reconocimientos y Premios

  • 🏆 1er Lugar BRAIN Chile UC-Santander 2023
  • 🏆 1er Lugar Impacto Emprendedor UDD-Banco de Chile 2023
  • 🏆 Human Health Award Big Bang! UC Davis 2024 (USD 12.500)
  • 🏆 LEGADO Award Fundación Bayer Salud 2024
  • 🏆 Ganador StartUp Ciencia 2024 ANID-CORFO
  • 🏆 1er Lugar PLASMA 2026 Aggie Square UC Davis

Transparencia de Datos

Nos comprometemos con la transparencia. Datos clínicos disponibles en solicitud formal a hello@candelmed.com para investigadores, clínicos y pacientes interesados.

Best-selling

What is tDCS?

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation (NIBS) technique. It is based on the controlled application of a low-intensity electrical current, vibrating between 1 and 2 milliamperes (mA), through the placement of two electrodes, one anodal and one cathodal, on the surface of the brain. tDCS is an emerging therapy for neurological conditions.

Scientific evidence of tDCS

Combined therapy of bilateral transcranial direct current stimulation and ocular occlusion improves visual function in adults with amblyopia, a randomized pilot study

 More information here

The effects of transcranial direct-current stimulation (tDCS) on pain intensity of patients with fibromyalgia: a systematic review and meta-analysis

 More information here

Early transcranial direct current stimulation with modified constraint-induced movement therapy for motor and functional upper limb recovery in hospitalized patients with stroke: A randomized, multicentre, double-blind, clinical trial.

 More information here

Our commitment to patient well-being

At Candel, we are dedicated to providing safe and quality rehabilitation, accessible to all. With cutting-edge medical technology, we work tirelessly to develop innovations that will improve the future of neurology, ensuring that every patient receives the best possible care.

We are on Mercado Público!

We are the only national company that commercializes neurostimulators in Mercado Público, facilitating access to advanced technology for neurological rehabilitation.

OUR

SPECIALISTS

Raúl Castillo

Physician from the University of Chile. PhD candidate in Biomedical Engineering at the University of California, Davis. Founder and CEO.

Lucía Del Valle

MD from the University of Chile. PhD candidate in Medical Sciences and specialist in Neurology from the University of Chile. Co-founder and CSO.

OUR ADVISORS

Prof. Dr. Nigel Pedersen

Neurologist and Epileptologist. Associate Professor and Director of Research, Department of Neurology, UC Davis. Scientific and Medical Advisor.

Prof. Dr. Rómulo Fuentes Flores

Mentor and Technical-Scientific Advisor. Director of Research at the Faculty of Medicine, University of Chile.

Prof. Dr. José Manuel Matamala

Neurologist at Clínica Alemana - PhD in Medical Sciences. Scientific and Medical Advisor.
crea una imagen de invvestigadores/neurologos

FOR RESEARCHERS

At Candel Medical Company, we support the development of clinical and scientific research in neuromodulation technologies.

Our Researchers Program is designed to facilitate access to technology, offer preferential conditions, and support projects seeking to generate evidence and advance innovation in healthcare.

If you are conducting research or have a project in the planning stage, we would like to hear from you.

Contact us at: contacto@candelmed.cl

Subject: Researchers Program